The dog studies that exist, and what each one actually tested

Beagles in a drug-development lab

Two papers from one research group used healthy laboratory beagles while developing BPC-157 as a human wound drug. One tracked how the body takes up and clears the substance. The other checked for harm.

The dogs broke it down fast: half of it was gone from the blood in under 30 minutes. When the dogs received it repeatedly, the study reported no abnormal changes except a drop in creatinine, a substance measured in blood, at the highest amount tested. It returned to normal within two weeks after testing stopped.

The researchers tested their own material in healthy lab dogs. They were looking for harmful effects, not treating injured pets. Finding little harm under those conditions cannot establish that an online product is safe for your dog.

A paw-pad wound study from 1996

The experiment used 12 laboratory dogs with small cuts made in their paw pads. Some pads received an injection of copper joined to a peptide made of three small building blocks. After two weeks, those pads had more of one kind of collagen, a material in skin and other body tissues, than pads injected with salt water. The authors reported helpful effects on wound healing.

The paper does not name the peptide, so it is not confirmed that it was GHK-Cu. It covers planned wounds in healthy dogs, and it says nothing about injections sold for joints, the gut or aging.

A weight drug in older Golden Retrievers

Liraglutide is a human medicine of the GLP-1 type: it copies a gut signal that raises insulin when blood sugar is high and reduces appetite. One small study gave it to 7 overweight senior Golden Retrievers over 40 days. Appetite dropped, but their weight loss was too small to rule out chance, and the authors asked for longer trials.

Searches in September 2026 found no published study of semaglutide or tirzepatide in pet dogs. In April 2025, developers working on a device placed in cats to slowly release a GLP-1 medicine announced plans for a dog version. A search in September 2026 found no published dog results.

Collagen chews are a different product

In a study of 31 dogs with painful, stiff joints from arthritis, dogs ate a supplement made of small pieces of collagen. Researchers compared it with a dummy treatment and found improvements in tests of how the dogs walked. The recorded summary does not say whether they limped less or walked farther. The collagen maker funded the work and employed one author.

It says nothing about injected peptides such as BPC-157, and a supplement is not an FDA-approved drug.

Rats, mice and a handful of people

Rats and mice account for most research on BPC-157. A review published in 2026 examined one group of rat studies. It judged the results worth further lab work, but insufficient to call BPC-157 a proven treatment.

The human findings come from three small, early studies involving fewer than 30 people altogether. Even after more than 30 years of research, no study had finished the next stage of testing how well it works in people, known as Phase II.

What is missing for dogs

PubMed searches on September 30, 2026 turned up nothing that tried KPV, TB-500 or BPC-157 as a remedy for sick or injured pet dogs.

PubMed is a searchable collection of research papers. Checking it on one date cannot prove that no study exists anywhere. No published dog treatment study supporting those claims was found in that search.